Literature DB >> 11383876

Lipopolysaccharide alters ecto-ATP-diphosphohydrolase and causes relocation of its reaction product in experimental intrahepatic cholestasis.

V S Zinchuk1, T Okada, H Seguchi.   

Abstract

Lipopolysaccharide (LPS), a bacterial endotoxin, exerts profound inflammatory actions toward various tissues and cells. We induced intrahepatic cholestasis in rats by administration of LPS and followed ecto-ATP-diphosphohydrolase (ecto-apyrase) activity in the liver. The activity of the enzyme had decreased to 77% 2 h after injection compared with the activity in control animals. The maximum decrease was detected 24 h after administration. The activity was found to have partially recovered 1 week after injection, but had yet to reach control levels. In contrast to the decrease in ecto-apyrase activity, there were increases in alkaline phosphatase activity and bilirubin concentration, markers of cholestasis. In response to LPS, the reaction product of ecto-apyrase was found to relocate from the canalicular domain of the plasma membrane of hepatocytes, its predominant localization in the liver of intact animals, to the basolateral and sinusoidal domains. The pattern of histochemical reaction indicated modulation of the enzyme activity and changes in trafficking of intracellular proteins. Taken together, our findings showed that LPS administration alters ecto-apyrase and causes relocation of its reaction product from the canalicular domain of the plasma membrane of hepatocytes in the rat. It is suggested that relocation of the reaction product may be a protective mechanism to enable the hepatocytes to withstand the cytokine-induced metabolic perturbations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383876     DOI: 10.1007/s004410000339

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  4 in total

1.  Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3.

Authors:  Michel Fausther; Julie Pelletier; Carla M Ribeiro; Jean Sévigny; Maryse Picher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

2.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  E-NTPDases in human airways: Regulation and relevance for chronic lung diseases.

Authors:  Lauranell H Burch; Maryse Picher
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

4.  Loss of ectonucleotidases from the coronary vascular bed after ischemia-reperfusion in isolated rat heart.

Authors:  Kaoru Takahashi-Sato; Masahiro Murakawa; Junko Kimura; Masa-aki Ito; Isao Matsuoka
Journal:  BMC Cardiovasc Disord       Date:  2013-07-28       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.